Malaysia's Parliamentary Special Select Committee on Health has moved decisively toward a structural overhaul of the national organ donation and transplant framework, following an extensive examination of governance, clinical practice, workforce development, resource allocation, and community engagement across the sector. The committee's chairman, Suhaizan Kaiat, unveiled the recommendations to the Dewan Rakyat on July 6, emphasising that incremental tinkering no longer suffices to address the systemic challenges constraining organ availability and transplant capacity nationwide.
The crux of the committee's agenda centres on enacting fresh legislation to supersede the Human Tissues Act 1974, a statute that has endured for half a century despite substantial evolution in transplantation science and medical ethics. The proposed law would formally recognise brain death as a criterion for donation, allow transplantation following circulatory death, and establish the concept of national organ ownership—a framework shift that would harmonise Malaysia's approach with international best practice in countries such as Spain and France, which have achieved among the world's highest donation rates through presumed consent models.
The National Transplant Resource Centre, currently functioning as a coordination body, would be significantly empowered under the reform agenda. Suhaizan outlined that the NTRC should emerge as the paramount authority governing policy formulation, clinical standards, specialist training, and comprehensive data administration across all organ donation and transplantation activities. Critical to this vision is the deployment of a real-time data monitoring and organ allocation system designed to enhance operational transparency, enable continuous performance auditing, and facilitate evidence-based decision-making at all levels of the health system.
Regulation of cross-border transplant activities represents another pillar of the proposed reform, reflecting concerns about unethical practices and ensuring that Malaysian patients accessing transplants abroad do so within robust oversight frameworks. This measure acknowledges the reality that some Malaysians, particularly those with financial means, pursue transplants internationally, a phenomenon that demands monitoring to uphold ethical standards and protect vulnerable populations from exploitation.
Financial barriers to transplant access emerged as a significant concern in the committee's deliberations. The recommendation calls for the Ministry of Health and Ministry of Finance to establish a dedicated fund supporting low-income transplant recipients, specifically addressing the burden of lifelong immunosuppressive medication, post-transplant follow-up care, and surgical procedures undertaken in private hospital settings where necessary. This targeted intervention acknowledges that transplant success depends not merely on the surgical procedure itself but on sustained access to expensive maintenance therapies that low-income families struggle to afford.
Meanwhile, Bank Negara Malaysia has been asked to investigate mechanisms for enhancing financial accessibility to organ transplantation services, though the original recommendations were incomplete in the source material. The committee's engagement of the central bank signals recognition that transplant affordability transcends conventional health budgeting and may benefit from innovative financing approaches such as insurance schemes or subsidised credit facilities.
Integrating organ donor registration into existing national digital infrastructure represents a practical innovation with immediate implementation potential. By linking the registration system with MySejahtera, driving licences, and identity cards, the committee aims to dramatically simplify the process for Malaysian citizens to formally register as donors. This approach builds on existing infrastructure and behavioural touchpoints, potentially transforming registration from a deliberate, bureaucratic exercise into an integrated feature of routine civil transactions.
The scale of unmet need underscores the urgency of these reforms. As of June 30, Malaysia had completed 3,657 transplant procedures, yet 10,170 patients languished on waiting lists for deceased donor organs. More poignantly, the committee identified that over 1,100 potential organ donations failed to materialise annually due to family refusal—a figure suggesting that supply-side constraints reflect not merely biological availability but organisational and attitudinal barriers. This gap points to the critical importance of strengthening public education, building confidence in the transplant system's governance and equity, and addressing cultural and religious concerns through sustained community engagement.
The projection of dialysis demand illustrates the mounting pressure on Malaysia's renal care capacity. Currently exceeding 55,000 patients dependent on dialysis, the population requiring renal replacement therapy is anticipated to surpass 104,000 by 2040—a trajectory that imposes enormous fiscal burdens, with annual dialysis costs approaching RM2 billion. Increasing transplant rates would not only improve patient outcomes and quality of life but also redirect healthcare resources toward other priorities, creating both humanitarian and economic imperatives for system reform.
The committee further advocated for strengthening human capital in the transplant sector through enhanced career pathways for specialists, formal recognition of transplantation as a national priority area, guaranteed annual budget allocations, and geographic expansion of transplant centres beyond existing concentrated hubs. These recommendations address the reality that transplantation has long struggled for visibility and resources within broader health policy, competing against more politically salient conditions for ministerial attention and funding.
Suhaizan's closing remarks reframed the entire reform agenda as transcending mere quantitative targets around donation and procedure numbers. Rather, the committee envisions constructing a transplant ecosystem characterised by operational efficiency, coherent organisation, public trust, and genuine capacity to serve patient needs equitably throughout the country. This reorientation shifts the conversation from transplant programmes as specialised clinical niches toward integrated, high-performing systems embedded within national health infrastructure—a transformation that would position Malaysia competitively within Southeast Asia and signal commitment to protecting citizen health across the lifespan.
